Brian T. Helfand

9.8k total citations · 1 hit paper
222 papers, 5.0k citations indexed

About

Brian T. Helfand is a scholar working on Pulmonary and Respiratory Medicine, Urology and Rheumatology. According to data from OpenAlex, Brian T. Helfand has authored 222 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Pulmonary and Respiratory Medicine, 57 papers in Urology and 40 papers in Rheumatology. Recurrent topics in Brian T. Helfand's work include Prostate Cancer Diagnosis and Treatment (78 papers), Prostate Cancer Treatment and Research (74 papers) and Urinary Bladder and Prostate Research (52 papers). Brian T. Helfand is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (78 papers), Prostate Cancer Treatment and Research (74 papers) and Urinary Bladder and Prostate Research (52 papers). Brian T. Helfand collaborates with scholars based in United States, China and Canada. Brian T. Helfand's co-authors include Robert D. Goldman, Susan L. McGovern, Kevin T. McVary, Brian K. Shoichet, Brian Y. Feng, William J. Catàlona, Lynne Chang, Melissa G. Mendez, Stacy Loeb and Boris Grin and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Brian T. Helfand

208 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder

2024 41 citations Doreen E. Chung, Elodi Dielubanza et al. profile →

Peers

Countries citing papers authored by Brian T. Helfand

Since Specialization

Citations

This map shows the geographic impact of Brian T. Helfand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian T. Helfand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian T. Helfand more than expected).

Fields of papers citing papers by Brian T. Helfand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian T. Helfand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian T. Helfand. The network helps show where Brian T. Helfand may publish in the future.

Co-authorship network of co-authors of Brian T. Helfand

This figure shows the co-authorship network connecting the top 25 collaborators of Brian T. Helfand. A scholar is included among the top collaborators of Brian T. Helfand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian T. Helfand. Brian T. Helfand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and validation of a genetic probability for venous thromboembolism 2025 ·Research and Practice in Thrombosis and Haemostasis ·Zhuqing Shi, (unknown), Van Huy Tran, (unknown), (unknown), Shuhua Xie, Jeffrey S. Lobel, Jun Wei, (unknown), (unknown), Siqun L. Zheng, (unknown), David Duggan, Brian T. Helfand, Arman Qamar, Alan R. Sanders, Alfonso Tafur, Jianfeng Xu	0
2	The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder 2024 ·Neurourology and Urodynamics ·Anne P. Cameron, Doreen E. Chung, Elodi Dielubanza, Ekene Enemchukwu, (unknown), Brian T. Helfand, Brian J. Linder, William M. Reynolds, Eric S. Rovner, Lesley Souter, Anne M. Suskind, Elizabeth Takacs, Blayne Welk, Ariana L. Smith	9
3	Enhanced clinical decisions for management of benign prostatic hyperplasia using patient-reported outcomes: protocol for a prospective observational study 2024 ·BMC Urology ·Alexander P. Glaser, Abigail R. Smith, (unknown), Brian T. Helfand, (unknown), (unknown), (unknown), Pooja Talaty, (unknown), (unknown), Francesca R Farina, Sally E. Jensen, James W. Griffith	1
4	Phenotyping Men With Lower Urinary Tract Symptoms: Results From the Symptoms of Lower Urinary Tract Dysfunction Research Network 2024 ·Neurourology and Urodynamics ·Margaret Helmuth, Abigail R. Smith, Alexander P. Glaser, (unknown), Anne P. Cameron, H. Henry Lai, James W. Griffith, J. Eric Jelovsek, J. Quentin Clemens, Brian T. Helfand, Robert M. Merion, Victor P. Andreev, (unknown)	0
5	Utility of Polygenic Scores for Differentiating Diabetes Diagnosis Among Patients With Atypical Phenotypes of Diabetes 2023 ·The Journal of Clinical Endocrinology & Metabolism ·Liana K. Billings, Zhuqing Shi, Jun Wei, (unknown), S. Lilly Zheng, Brian T. Helfand, (unknown), Henry M. Dunnenberger, Peter J. Hulick, Arman Qamar, Jianfeng Xu	4
6	KLK3 germline mutation I179T complements DNA repair genes for predicting prostate cancer progression 2022 ·Prostate Cancer and Prostatic Diseases ·Jianfeng Xu, Zhuqing Shi, Jun Wei, Rong Na, (unknown), Chi‐Hsiung Wang, Christopher Sample, Misop Han, S. Lilly Zheng, Kathleen A. Cooney, Brian T. Helfand, William B. Isaacs	2
7	Association of prostate cancer polygenic risk score with number and laterality of tumor cores in active surveillance patients 2021 ·The Prostate ·Jianfeng Xu, William B. Isaacs, Mufaddal Mamawala, Zhuqing Shi, Patricia Landis, Jacqueline Petkewicz, Jun Wei, Chi‐Hsiung Wang, (unknown), Rong Na, (unknown), Kristian Novakovic, Patrick C. Walsh, Su-Su Zheng, Brian T. Helfand, Christian P. Pavlovich	9
8	Observed evidence for guideline‐recommended genes in predicting prostate cancer risk from a large population‐based cohort 2021 ·The Prostate ·Jun Wei, Wancai Yang, Zhuqing Shi, Lucy Lu, (unknown), (unknown), (unknown), S. Lilly Zheng, Peter J. Hulick, Kathleen A. Cooney, William B. Isaacs, Brian T. Helfand, Jim Lu, Jianfeng Xu	10
9	Association of germline rare pathogenic mutations in guideline‐recommended genes with prostate cancer progression: A meta‐analysis 2021 ·The Prostate ·Zhuqing Shi, Lucy Lu, (unknown), Wancai Yang, Jun Wei, Qiang Wang, (unknown), Siqun L. Zheng, Kathleen A. Cooney, William B. Isaacs, Brian T. Helfand, Jim Lu, Jianfeng Xu	9
10	Rare Germline Pathogenic Mutations of DNA Repair Genes Are Most Strongly Associated with Grade Group 5 Prostate Cancer 2020 ·European Urology Oncology ·Yishuo Wu, Hongjie Yu, Shuwei Li, Kathleen E. Wiley, Shun Zheng, Holly LaDuca, Marta Gielzak, Rong Na, Brice A. J. Sarver, Brian T. Helfand, Patrick C. Walsh, Tamara L. Lotan, Kathleen A. Cooney, Mary Helen Black, Jianfeng Xu, William B. Isaacs	38
11	The association of popular diets and erectile function among men in the United States 2020 ·International Journal of Impotence Research ·Richard J Fantus, Joshua A. Halpern, Cecilia Chang, Mary Kate Keeter, Robert E. Brannigan, Brian T. Helfand, Nelson Bennett	3
12	The association between guideline‐based exercise thresholds and low testosterone among men in the United States 2020 ·Andrology ·Richard J Fantus, Cecilia Chang, (unknown), Nelson Bennett, Robert E. Brannigan, Brian T. Helfand, Joshua A. Halpern	3
13	Validation of a prostate cancer polygenic risk score 2020 ·The Prostate ·Mary Helen Black, Shuwei Li, Holly LaDuca, Min‐Tzu Lo, Jefferey Chen, (unknown), Stephanie Gutierrez, (unknown), Hsiao‐Mei Lu, Marta Gielzak, Kathleen E. Wiley, Zhuqing Shi, Jun Wei, Siqun L. Zheng, Brian T. Helfand, William B. Isaacs, Jianfeng Xu	19
14	Concept and benchmarks for assessing narrow‐sense validity of genetic risk score values 2019 ·The Prostate ·Hongjie Yu, Zhuqing Shi, Yishuo Wu, Chi‐Hsiung Wang, Xiaoling Lin, (unknown), William B. Isaacs, Brian T. Helfand, S. Lilly Zheng, David Duggan, Zengnan Mo, Daru Lu, Jianfeng Xu	14
15	Systematic evaluation of cancer‐specific genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical Records and Genomics cohorts 2019 ·Cancer Medicine ·Zhuqing Shi, Hongjie Yu, Yishuo Wu, Xiaoling Lin, (unknown), (unknown), (unknown), David Duggan, Brian T. Helfand, Siqun L. Zheng, Jianfeng Xu	18
16	Broad‐ and narrow‐sense validity performance of three polygenic risk score methods for prostate cancer risk assessment 2019 ·The Prostate ·Hongjie Yu, Zhuqing Shi, Xiaoling Lin, (unknown), (unknown), Jun Wei, Brian T. Helfand, Siqun L. Zheng, David Duggan, Daru Lu, Zengnan Mo, Jianfeng Xu	6
17	Mutational Landscape of Aggressive Prostate Tumors in African American Men 2016 ·Cancer Research ·Karla Lindquist, Pamela L. Paris, Thomas J. Hoffmann, Niall J. Cardin, Rémi Kazma, Joel Mefford, Jeffrey P. Simko, Vy Ngo, Yalei Chen, Albert M. Levin, Dhananjay Chitale, Brian T. Helfand, William J. Catàlona, Benjamin A. Rybicki, John S. Witte	54
18	Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor β–Insensitive CD8+ T Cells 2009 ·Clinical Cancer Research ·Longxin Wang, Weihong Wen, Jianlin Yuan, Brian T. Helfand, Li Yu, Changhong Shi, Feng Tian, (unknown), Fuli Wang, Lin Chen, Li‐Li Liang, Liqun Zhou, Chung Lee, Zhi‐Nan Chen, Yinglu Guo, He Wang, Qiang Zhang, Weijun Qin	35
19	Nuclear Factor-κB-Mediated Transforming Growth Factor-β-Induced Expression of Vimentin Is an Independent Predictor of Biochemical Recurrence after Radical Prostatectomy 2009 ·Clinical Cancer Research ·Qiang Zhang, Brian T. Helfand, Thomas L. Jang, Lihua Julie Zhu, Lin Chen, Ximing J. Yang, James M. Kozlowski, Norm D. Smith, Shilajit Kundu, Guang‐Yu Yang, Adekunle Raji, Borko Javonovic, Michael Pins, Paul F. Lindholm, (unknown), William J. Catàlona, Chung Lee	93
20	Introducing intermediate filaments: from discovery to disease 2009 ·Journal of Clinical Investigation ·John Eriksson, Thomas Dechat, Boris Grin, Brian T. Helfand, Melissa G. Mendez, (unknown), Robert D. Goldman	332

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact